Surgical approach with vascular reconstruction after an objective response to neoadjuvant therapy with an EGFR tyrosine kinase inhibitor: clinical case. (2022). Voprosy Onkologii, 67(2), 278-281. https://doi.org/10.37469/0507-3758-2021-67-2-278-281